In this touchENDOCRINOLOGY interview, Dr Ashu Rastogi (Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India) discusses the first randomized, double-blind, placebo-controlled, parallel-group, multi-centre, phase III study evaluating the efficacy of topical esmolol for diabetic foot ulcer healing. Dr Ashu Rastogi also discusses how these results support physicians in providing optimized care for people with diabetic foot ulcers.
The abstract entitled: ‘Novel topical esmolol hydrochloride for diabetic foot ulcer: phase 3, randomised, double-blind, placebo-controlled, multi-centre study’ was presented at the European Association for the Study of Diabetes, 19-23 Sept, 2022.
Questions:
- What were your findings for topical esmolol in the treatment of diabetic foot ulcers, both versus, and in addition to, standard of care? (0:25)
- How can these results support physicians in providing optimized care for people with diabetic foot ulcers? (2:45)
Disclosures: Ashu Rastogi has nothing to disclose in relation to this video interview.
Support: Interview supported by Touch Medical Media. Interview conducted by Shanice Allen.
Recorded as a highlight of EASD 2022
